Enhancing chimeric antigen receptor T‐cell immunotherapy against cancer using a nanoemulsion‐based vaccine targeting cross‐presenting dendritic cells - Concepedia

Concepedia

Publication | Open Access

Enhancing chimeric antigen receptor T‐cell immunotherapy against cancer using a nanoemulsion‐based vaccine targeting cross‐presenting dendritic cells

DOI Full Paper Access

38

Citations

25

References

2020

Year

Jack D. Chan, Bianca von Scheidt, Bijun Zeng, Amanda J. Oliver, Ashleigh S Davey, Aesha I. Ali, Ranjeny Thomas, Joseph A. Trapani, Phillip K. Darcy, Michael H. Kershaw,

Clinical & Translational Immunology

Abstract

Our study presents Clec9A-TNE as a prospective avenue to enhance CAR T-cell efficacy for solid cancers.

References

	Year	Citations
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia Stephan A. Grupp, Michael Kalos, David M. Barrett, New England Journal of Medicine T-regulatory CellImmune RegulationImmunologyImmunodominanceCd4 T Cell Responses	2013	3.4K
T cell receptor antagonist peptides induce positive selection Kristin A. Hogquist, Stephen C. Jameson, William R. Heath, Cell T-regulatory CellImmunologyPositive SelectionAutoimmunityTolerance Induction	1994	2.8K
Human Lymphoid and Myeloid Cell Development in NOD/LtSz- <i>scid IL2R</i> γ <i>null</i> Mice Engrafted with Mobilized Human Hemopoietic Stem Cells, Leonard D. Shultz, Bonnie Lyons, Lisa Burzenski, The Journal of Immunology	2005	1.7K
Defective TCR expression in transgenic mice constructed using cDNA‐based α‐ and β‐chain genes under the control of heterologous regulatory elements Megan Barnden, Jan Allison, William R. Heath Immunology and Cell Biology	1998	1.5K
Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19 James N. Kochenderfer, Wyndham H. Wilson, John E. Janik, Blood	2010	1.3K
An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors Katharina Reinhard, Benjamin Rengstl, Petra Oehm, Science	2020	479
The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement Irina Caminschi, Anna I. Proietto, Fatma Ahmet, Blood	2008	465
Enhanced CAR–T cell activity against solid tumors by vaccine boosting through the chimeric receptor Leyuan Ma, Tanmay Dichwalkar, Jason Y.H. Chang, Science Solid TumorsImmunologyCd4 T Cell ResponsesBiomedical EngineeringImmunotherapy	2019	412
Density of DC-LAMP+ mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor Andrea Ladányi, Judit Kiss, Beáta Somlai, Cancer Immunology Immunotherapy MelanomaImmunologyAutoimmunityPrimary Cutaneous MelanomaDermatology	2007	276
The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells Gerty Schreibelt, Lieke J.J. Klinkenberg, Luis J. Cruz, Blood	2012	241

Page 1